https://www.tempus.com/publications/tumor-mutational-burden-and-other-predictive-immunotherapy-markers-in-histiocytic-neoplasms/
Tumor Mutational Burden and Other Predictive Immunotherapy Markers in Histiocytic Neoplasms - Tempus
Nov 10, 2022 - Histiocytic neoplasms are rare hematological disorders that have diverse clinical manifestations and can pose significant management challenges for clinicians....
histiocytic neoplasmstumorburdenpredictiveimmunotherapy
https://scholars.duke.edu/publication/1584296
Scholars@Duke publication: B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic...
b cell lineagescholarsdukepublicationneoplasms